Genmab
GMAB
$26.70
Share price
2.29%
Change (1 day)
-34.32%
Change (1 year)
Categories
EPS for Genmab (GMAB)
EPS in 2023 (TTM): $1.36
According to Genmab's latest financial reports the company's current EPS (TTM) is $1.40. In 2022 the company made an earnings per share (EPS) of $1.62 an increase over its 2021 EPS that were of $1.00.
EPS history for Genmab from 2009 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $1.36 | -15.74% |
| 2022 | $1.62 | 62.07% |
| 2021 | $1.00 | -35.78% |
| 2020 | $1.55 | 119.14% |
| 2019 | $0.71 | 36.35% |
| 2018 | $0.52 | 29.83% |
| 2017 | $0.40 | 0.92% |
| 2016 | $0.40 | 47.69% |
| 2015 | $0.27 | 109.32% |
| 2014 | $0.13 | 134.03% |
| 2013 | $0.05479 | -121.08% |
| 2012 | -$0.26 | -23.69% |
| 2011 | -$0.34 | 94.77% |
| 2010 | -$0.17 | -70.48% |
| 2009 | -$0.59 |